Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
一项针对18-59岁健康成年人的随机、双盲、安慰剂对照的1/2期临床试验,评估了灭活SARS-CoV-2疫苗的安全性、耐受性和免疫原性。
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(20)30843-4
Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin; Hu, Yuansheng; Liu, Xiaoyong; Jiang, Congbing; Li, Jingxin; Yang, Minnan; Song, Yan; Wang, Xiangxi; Gao, Qiang; Zhu, Fengcai